[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Inhalational Anaesthesia Drugs Market - Global Outlook and Forecast 2021-2027

April 2021 | 93 pages | ID: IE91685EB840EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Inhalational Anaesthesia Drugs in Global, including the following market information:

Global Inhalational Anaesthesia Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Inhalational Anaesthesia Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inhalational Anaesthesia Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Inhalational Anaesthesia Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Inhalational Anaesthesia Drugs Market Segment Percentages, By Type, 2020 (%)
  • Enflurane
  • Isoflurane
  • Halothane
  • Sevoflurane
  • Atropine
China Inhalational Anaesthesia Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Inhalational Anaesthesia Drugs Market Segment Percentages, By Application, 2020 (%)
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Global Inhalational Anaesthesia Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Inhalational Anaesthesia Drugs Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Inhalational Anaesthesia Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Inhalational Anaesthesia Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • AbbVie Inc.
  • Baxter
  • Hikma Pharmaceuticals PLC
  • Halocarbon Products Corporation
  • Piramal Enterprises Limited
  • Lunan Pharmaceutical Group Co. Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Von Hippel-Lindau Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Von Hippel-Lindau Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VON HIPPEL-LINDAU TREATMENT OVERALL MARKET SIZE

2.1 Global Von Hippel-Lindau Treatment Market Size: 2021 VS 2027
2.2 Global Von Hippel-Lindau Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Von Hippel-Lindau Treatment Players in Global Market
3.2 Top Global Von Hippel-Lindau Treatment Companies Ranked by Revenue
3.3 Global Von Hippel-Lindau Treatment Revenue by Companies
3.4 Top 3 and Top 5 Von Hippel-Lindau Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Von Hippel-Lindau Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Von Hippel-Lindau Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Von Hippel-Lindau Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Von Hippel-Lindau Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Von Hippel-Lindau Treatment Market Size Markets, 2021 & 2027
  4.1.2 MRI Scan
  4.1.3 CT Scan
  4.1.4 Others
4.2 By Type - Global Von Hippel-Lindau Treatment Revenue & Forecasts
  4.2.1 By Type - Global Von Hippel-Lindau Treatment Revenue, 2016-2021
  4.2.2 By Type - Global Von Hippel-Lindau Treatment Revenue, 2022-2027
  4.2.3 By Type - Global Von Hippel-Lindau Treatment Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Von Hippel-Lindau Treatment Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Diagnostic Centers
  5.1.5 Others
5.2 By Application - Global Von Hippel-Lindau Treatment Revenue & Forecasts
  5.2.1 By Application - Global Von Hippel-Lindau Treatment Revenue, 2016-2021
  5.2.2 By Application - Global Von Hippel-Lindau Treatment Revenue, 2022-2027
  5.2.3 By Application - Global Von Hippel-Lindau Treatment Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Von Hippel-Lindau Treatment Market Size, 2021 & 2027
6.2 By Region - Global Von Hippel-Lindau Treatment Revenue & Forecasts
  6.2.1 By Region - Global Von Hippel-Lindau Treatment Revenue, 2016-2021
  6.2.2 By Region - Global Von Hippel-Lindau Treatment Revenue, 2022-2027
  6.2.3 By Region - Global Von Hippel-Lindau Treatment Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Von Hippel-Lindau Treatment Revenue, 2016-2027
  6.3.2 US Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.3.3 Canada Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.3.4 Mexico Von Hippel-Lindau Treatment Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Von Hippel-Lindau Treatment Revenue, 2016-2027
  6.4.2 Germany Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.4.3 France Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.4.4 U.K. Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.4.5 Italy Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.4.6 Russia Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.4.7 Nordic Countries Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.4.8 Benelux Von Hippel-Lindau Treatment Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Von Hippel-Lindau Treatment Revenue, 2016-2027
  6.5.2 China Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.5.3 Japan Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.5.4 South Korea Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.5.5 Southeast Asia Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.5.6 India Von Hippel-Lindau Treatment Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Von Hippel-Lindau Treatment Revenue, 2016-2027
  6.6.2 Brazil Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.6.3 Argentina Von Hippel-Lindau Treatment Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Von Hippel-Lindau Treatment Revenue, 2016-2027
  6.7.2 Turkey Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.7.3 Israel Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.7.4 Saudi Arabia Von Hippel-Lindau Treatment Market Size, 2016-2027
  6.7.5 UAE Von Hippel-Lindau Treatment Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Eli Lilly and Company
  7.1.1 Eli Lilly and Company Corporate Summary
  7.1.2 Eli Lilly and Company Business Overview
  7.1.3 Eli Lilly and Company Von Hippel-Lindau Treatment Major Product Offerings
  7.1.4 Eli Lilly and Company Von Hippel-Lindau Treatment Revenue in Global (2016-2021)
  7.1.5 Eli Lilly and Company Key News
7.2 Bedford Laboratories
  7.2.1 Bedford Laboratories Corporate Summary
  7.2.2 Bedford Laboratories Business Overview
  7.2.3 Bedford Laboratories Von Hippel-Lindau Treatment Major Product Offerings
  7.2.4 Bedford Laboratories Von Hippel-Lindau Treatment Revenue in Global (2016-2021)
  7.2.5 Bedford Laboratories Key News
7.3 DNAtrix, Inc.
  7.3.1 DNAtrix, Inc. Corporate Summary
  7.3.2 DNAtrix, Inc. Business Overview
  7.3.3 DNAtrix, Inc. Von Hippel-Lindau Treatment Major Product Offerings
  7.3.4 DNAtrix, Inc. Von Hippel-Lindau Treatment Revenue in Global (2016-2021)
  7.3.5 DNAtrix, Inc. Key News
7.4 Astellas US Holding, Inc.
  7.4.1 Astellas US Holding, Inc. Corporate Summary
  7.4.2 Astellas US Holding, Inc. Business Overview
  7.4.3 Astellas US Holding, Inc. Von Hippel-Lindau Treatment Major Product Offerings
  7.4.4 Astellas US Holding, Inc. Von Hippel-Lindau Treatment Revenue in Global (2016-2021)
  7.4.5 Astellas US Holding, Inc. Key News
7.5 Advantagene, Inc
  7.5.1 Advantagene, Inc Corporate Summary
  7.5.2 Advantagene, Inc Business Overview
  7.5.3 Advantagene, Inc Von Hippel-Lindau Treatment Major Product Offerings
  7.5.4 Advantagene, Inc Von Hippel-Lindau Treatment Revenue in Global (2016-2021)
  7.5.5 Advantagene, Inc Key News
7.6 Burzynski Research Institute, Inc.
  7.6.1 Burzynski Research Institute, Inc. Corporate Summary
  7.6.2 Burzynski Research Institute, Inc. Business Overview
  7.6.3 Burzynski Research Institute, Inc. Von Hippel-Lindau Treatment Major Product Offerings
  7.6.4 Burzynski Research Institute, Inc. Von Hippel-Lindau Treatment Revenue in Global (2016-2021)
  7.6.5 Burzynski Research Institute, Inc. Key News
7.7 Cellectar Biosciences, Inc.
  7.7.1 Cellectar Biosciences, Inc. Corporate Summary
  7.7.2 Cellectar Biosciences, Inc. Business Overview
  7.7.3 Cellectar Biosciences, Inc. Von Hippel-Lindau Treatment Major Product Offerings
  7.4.4 Cellectar Biosciences, Inc. Von Hippel-Lindau Treatment Revenue in Global (2016-2021)
  7.7.5 Cellectar Biosciences, Inc. Key News
7.8 Direct Therapeutics, Inc.
  7.8.1 Direct Therapeutics, Inc. Corporate Summary
  7.8.2 Direct Therapeutics, Inc. Business Overview
  7.8.3 Direct Therapeutics, Inc. Von Hippel-Lindau Treatment Major Product Offerings
  7.8.4 Direct Therapeutics, Inc. Von Hippel-Lindau Treatment Revenue in Global (2016-2021)
  7.8.5 Direct Therapeutics, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Inhalational Anaesthesia Drugs Market Opportunities & Trends in Global Market
Table 2. Inhalational Anaesthesia Drugs Market Drivers in Global Market
Table 3. Inhalational Anaesthesia Drugs Market Restraints in Global Market
Table 4. Key Players of Inhalational Anaesthesia Drugs in Global Market
Table 5. Top Inhalational Anaesthesia Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Inhalational Anaesthesia Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Inhalational Anaesthesia Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Inhalational Anaesthesia Drugs Product Type
Table 9. List of Global Tier 1 Inhalational Anaesthesia Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inhalational Anaesthesia Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Inhalational Anaesthesia Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Inhalational Anaesthesia Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Inhalational Anaesthesia Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Inhalational Anaesthesia Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Inhalational Anaesthesia Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Inhalational Anaesthesia Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2022-2027
Table 30. AbbVie Inc. Corporate Summary
Table 31. AbbVie Inc. Inhalational Anaesthesia Drugs Product Offerings
Table 32. AbbVie Inc. Inhalational Anaesthesia Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Baxter Corporate Summary
Table 34. Baxter Inhalational Anaesthesia Drugs Product Offerings
Table 35. Baxter Inhalational Anaesthesia Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Hikma Pharmaceuticals PLC Corporate Summary
Table 37. Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Product Offerings
Table 38. Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Halocarbon Products Corporation Corporate Summary
Table 40. Halocarbon Products Corporation Inhalational Anaesthesia Drugs Product Offerings
Table 41. Halocarbon Products Corporation Inhalational Anaesthesia Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Piramal Enterprises Limited Corporate Summary
Table 43. Piramal Enterprises Limited Inhalational Anaesthesia Drugs Product Offerings
Table 44. Piramal Enterprises Limited Inhalational Anaesthesia Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Lunan Pharmaceutical Group Co. Ltd. Corporate Summary
Table 46. Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Product Offerings
Table 47. Lunan Pharmaceutical Group Co. Ltd. Inhalational Anaesthesia Drugs Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Inhalational Anaesthesia Drugs Segment by Type
Figure 2. Inhalational Anaesthesia Drugs Segment by Application
Figure 3. Global Inhalational Anaesthesia Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Inhalational Anaesthesia Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Inhalational Anaesthesia Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Inhalational Anaesthesia Drugs Revenue in 2020
Figure 8. By Type - Global Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027
Figure 12. US Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027
Figure 24. China Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Inhalational Anaesthesia Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Inhalational Anaesthesia Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. AbbVie Inc. Inhalational Anaesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Baxter Inhalational Anaesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Hikma Pharmaceuticals PLC Inhalational Anaesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Halocarbon Products Corporation Inhalational Anaesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Piramal Enterprises Limited Inhalational Anaesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications